发明名称 |
THERAPEUTIC USE OF THE ß2-MICROGLOBULIN PROTEIN |
摘要 |
Pharmaceutical product (I) comprises beta2 microglobulin (beta2m) or a functional variant of the protein, as the active ingredient. Independent claims are included for: (1) composition comprising (I); and (2) method of diagnosing an autoimmune disease, comprising determining the ratio of long chain (CL)/beta2m major histocompatibility complex (MHC) complex of type I extracted from a patient. ACTIVITY : Immunosuppressive; Antiarthritic; Antirheumatic; Antiinflammatory; Dermatological; Muscular-Gen.; Antidiabetic; Endocrine-Gen.; Gastrointestinal-Gen.; Neuroprotective. MECHANISM OF ACTION : None given. |
申请公布号 |
PL2555790(T3) |
申请公布日期 |
2016.12.30 |
申请号 |
PL11717774T |
申请日期 |
2011.04.06 |
申请人 |
|
发明人 |
MERSEL MARCEL;RAKOTOARIVELO CLOVIS |
分类号 |
G01N33/564;A61K9/127;A61K38/17;A61P37/06 |
主分类号 |
G01N33/564 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|